Skip to content
Biodatica
Start free

Institut du Cancer de Montpellier - Val d'Aurelle

Montpellier, Bouches Du Rhône

OncologyPhase III
Sign in to watch

What changed

Phase III trial registered: Intensified Chemotherapy in CRC After Resection of Liver Metastases

5mo agoTrial registeredFeb 5, 2026Source filing (opens the source filing in a new tab)

Momentum

73no change

Momentum 73 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Nov 1, 2017

    Stage III Colon Cancer · ACTIVE_NOT_RECRUITING · sponsor: Institut du Cancer de Montpellier - Val d'Aurelle · LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy

    ClinicalTrials.gov · NCT03255434 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Sep 1, 2012

    Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors · COMPLETED · sponsor: Institut du Cancer de Montpellier - Val d'Aurelle · Sorafenib in Combination With Irinotecan in Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors

    ClinicalTrials.gov · NCT01715441 (opens the source filing in a new tab)

  3. Trial

    PHASE2/PHASE3 registered

    Apr 1, 2004

    Colorectal Cancer, Liver Metastases, Chemotherapy · COMPLETED · sponsor: Institut du Cancer de Montpellier - Val d'Aurelle · Intensified Chemotherapy in CRC After Resection of Liver Metastases

    ClinicalTrials.gov · NCT00208260 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources